Why are you looking at Adaptive Biotechnologies?
Email me when a Adaptive Biotechnologies recompete window opens.
Capability
Service linesRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) · MEDICAL LABORATORIES · TESTING LABORATORIES AND SERVICES
Work mix: 58% prime · 42% sub · primary NAICS 621511 / PSC Q301 REFERENCE LABORATORY TESTING
Where they win
3 agenciesMostly sole-source · 110%
110% of Adaptive Biotechnologies’s obligations are not openly competed — these contracts typically renew with the incumbent rather than going to recompete.
Agency buyer map
3 buyersRecompete exposure
LowLargely sole-source — these contracts typically renew with Adaptive Biotechnologies rather than being openly recompeted.
Adaptive Biotechnologies has an estimated $244K in contracts returning to market over the next 24 months. 1 within 6 months ($244K).
Adaptive Biotechnologies teams with
1Partners from federal subaward / teaming records (public).
“With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Adaptive Biotechnologies hold?
Adaptive Biotechnologies (UEI DMW5BNQ331K9) shows $843K across 24 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Adaptive Biotechnologies have?
Adaptive Biotechnologies shows $843K across 24 award actions. SCOUT tracks 1 incumbent recompetes ($244K) returning to market in the next 24 months.
Which agencies does Adaptive Biotechnologies work with?
Adaptive Biotechnologies’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (47%), Department of Defense (DOD) (44%), Department of Veterans Affairs (VA) (9%).
What is the UEI for Adaptive Biotechnologies?
The Unique Entity ID (UEI) for Adaptive Biotechnologies is DMW5BNQ331K9.
Does Adaptive Biotechnologies have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Adaptive Biotechnologies — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.